tVNS Health Gmbh is a medical technology sales company based in Grünwald, Germany, that has been responsible for the global distribution, services, and operations management of tVNS devices. tVNS® in Italy: tVNS Health GmbH | E. M. S. s. r. l tVNS Health GmbH is a medical technology sales company based in Germany, responsible for the global distribution, services, and sales of tVNS® non-invasive auricular vagus nerve stimulation devices in Eastern Europe, Scandinavia, Asia, Africa, South America and Italy. The developer and manufacturer of tVNS® devices is tVNS Technologies GmbH based in Erlangen, Germany. Since the medical approval of the Cerbomed Nemos® device as a first non-invasive auricular vagus nerve stimulation medical device in 2010, Cerbomed Nemos® and the new tVNS® have been used in thousands of treatments globally and significantly improved patients’ quality of life. E.M.S. s.r.l. is a commercial company founded in Bologna in 1994 and ISO-9001 certified. Specializing in the marketing of electromedical equipment and related software systems, the company has established itself as a reliable partner in the field of medical technology. With deep expertise in neuropsychology, neurology, neurorehabilitation, and neurosurgery, E.M.S. offers high-quality, innovative, and exclusive solutions. Thanks to its strong sales network and advanced organizational structure, the company serves both hospitals and neurophysiological research centers with products that exceed standard market quality. In Italy, E.M.S. s.r.l. is the official distributor of tVNS Health GmbH and tVNS Technologies GmbH , providing sales and support services for tVNS® devices and ensuring widespread access to neuromodulation treatments. tVNS Health GmbH Global Sales & Services: Südliche Münchner Str. 62, 82031 Grünwald, Germany info@tvns.health www.tvns.health E. M. S. s. r. l Distributor in Italy Via di Saliceto 81, 40128 Bologna Italy www.emsmedical.net Tel. +39-051396205 Contact Us

Transform Patient Care with tVNS® Empower your practice and patients with a non-invasive solution that enhances well-being without the need for medication. With its precise cymba concha stimulation and wireless parameter flexibility, tVNS® offers cutting-edge technology and unparalleled flexibility to explore new therapeutic protocols. Approved under as a Class IIa medical device under the EU-MDR, our tVNS® device ensures adherence to the highest standards of safety and efficacy in medical research. tVNS® Devices are Trusted by Leading Institutions Worldwide To play, press and hold the enter key. To stop, release the enter key. tVNS® R for Research Transcutaneous Vagus Nerve Stimulation Device for Research Full Wireless Parameter Programmability Patient App for Data Collection Support for Clinical Trials Triggered tVNS® Legacy and Hook Electrode Sham Stimulation Key Benefits for Patients EU-MDR Cla ss IIa Certified Medical Device tVNS® is the world's only non-invasive vagus nerve stimulation approved as a Class IIa medical device under the EU-MDR, offering a scientifically validated treatment for conditions related to sympathovagal imbalance. Non-Invasive Approach A safe and gentle alternative to surgery and medication, tVNS® stimulates the vagus nerve through the skin, offering a harmonious path to wellbeing with very low side-effects. Most Effective Stimulation Site tVNS® is the only non-invasive stimulation device that stimulates the cymba concha, resulting in 100% vagus nerve innervation (as opposed to e.g. the tragus, which only results in 45% innervation). Minimal Side Effects Transitioning away from traditional medications often aims to reduce side effects. tVNS®, as a drug-free therapy, offers a safer alternative with lower risk of long-term adverse effects. Why We Lead in Vagus Nerve Stimulation? For over 20 years, our commitment to innovation has positioned us at the forefront of non-invasive vagus nerve stimulation. Our unmatched research and development efforts are backed by solid clinical trials, ensuring our devices are not only effective but also safe and reliable. As an approved Class IIa medical device under the EU-MDR, we offer scientifically validated solutions in a market crowded with unverified alternatives. Since introducing the Cerbomed Nemos® device, we’ve led the market in non-invasive vagus nerve technology. Our pioneering approach and sustained innovation keep us ahead, with our devices being preferred by healthcare professionals and researchers worldwide due to unmatched safety, reliability and precision. Developed and manufactured in Germany, our devices meet the highest quality standards, reflecting our dedication to excellence and the well-being of our patients. Learn More About tVNS Health GmbH What is tVNS®? Elevating patient treatment options with non-invasive vagus nerve stimulation for the treatment of neurological diseases When traditional pharmacological or invasive treatments fall short or present challenging side effects, tVNS® offers an effective and patient-friendly treatment option. The vagus nerve, central to our body’s nervous system, plays a critical role in maintaining homeostasis. tVNS® , or Transcutaneous Vagus Nerve Stimulation , harnesses the therapeutic potential of this nerve through targeted stimulation of its auricular branch, accessible within the ear. This innovative approach utilizes gentle electrical impulses to modulate the vagus nerve’s activity, encouraging a state of balance across the body’s systems. The result? A reduction in the symptoms of neurological diseases associated with sympathovagal imbalance, achieved through a method that avoids the invasiveness of surgery and the side effects associated with medication. Approved as a Class IIa medical device under the European Medical Device Regulation (MDR), tVNS® sets a new standard in the treatment of neurological conditions, offering a blend of efficacy, safety, and simplicity. tVNS® is indicated to treat the following conditions: ✓Anxiety ✓Atrial fibrillation ✓Autism ✓Cognitive Impairment ✓Depression ✓Epilepsy ✓Irritable Bowel Syndrome ✓Inflammatory Bowel Disease ✓Migraines ✓Parkinson's Disease ✓Prader-Willi Syndrome ✓Sleep Disorders ✓Systemic Sclerosis ✓Tinnitus Treatment with tVNS® is characterized by its simplicity and adaptability to everyday life. At its core, tVNS® operates on the principle of neurostimulation, a process that engages the vagus nerve’s capacity to influence various bodily functions and systems. tVNS® stimulates the auricular branch of the vagus nerve (ABVN) through the skin with gentle and precise electrical impulses that propagate therapeutic signals to the brain, first to the brain stem and then to higher centers, aiming to correct dysregulation within the nervous system. The application of tVNS® is designed with the patient in mind: it is easy, portable, and discreet, making it possible to incorporate treatment sessions into your schedule without interruption to your daily tasks. Whether you’re at home, in the office, or traveling, tVNS® provides a consistent and accessible means to manage symptoms of neurological disorders, including the reduction of seizure frequencies in epilepsy, among other conditions. Each session with the tVNS® device is a step towards rebalancing the nervous system, leveraging the natural pathways of the body to foster healing and symptom relief. The device’s ease of use ensures that starting and maintaining a regimen with tVNS® is straightforward, empowering users to take control of their health in a non-intrusive, effective manner. How does treatment with tVNS® work? Patients can use tVNS® anytime, anywhere. It's easy to use, portable, and discrete. Research and Patient App Your tVNS® R device gives you access to two apps: the tVNS® Research and tVNS® Patient app. All technical parameters can easily be reprogrammed and wirelessly transmitted with the tVNS® Research app, allowing the researcher to try completely new stimulation protocols. In addition, you can collect and store technical and patient data. The tVNS® Patient app automatically stores all technical data (stimulation parameters, time and duration of the stimulation etc.) and offers a questionnaire for patient feedback. tVNS® Patient is fully compliant with the General Data Protection Regulation (GDPR), ensuring that patient data is handled with the utmost care and confidentiality. Why choose our tVNS® devices? Our tVNS® device is the only non-invasive vagus nerve stimulator that is approved as a Class IIa medical device under the European Medical Device Regulation (EU-MDR). tVNS® sets itself apart with its non-invasive, clinically validated approach, offering a safer and more comfortable alternative to invasive methods. Uniquely targeting the cymba concha for 100% innervation of the auricular branch of the vagus nerve (ABVN) with our patented electrode, tVNS® ensures maximum efficacy compared to other devices that only achieve partial innervation. EU-MDR Cla ss IIa Approved Medical Device Our tVNS® device is the only non-invasive vagus nerve stimulation (VNS) device that is approved as a medical device under the EU-MDR. It uniquely targets the Cymba Concha for 100% innervation of the auricular branch of the vagus nerve, unlike other devices that stimulate other areas and are not manufactured under the same quality and safety standards. EU-MDR Cla ss IIa Non-Surgical Approach tVNS® offers the efficacy of vagus nerve stimulation without the complexities or risks of surgical interventions. This means meaningful therapeutic benefits, all under your patient's control, without invasive procedures. EU-MDR Cla ss IIa Minimal Side Effects Transitioning away from traditional medications often comes with the pursuit of fewer side effects. tVNS®, being drug-free, ensures a therapeutic experience with reduced potential for long-term adverse outcomes, positioning itself as a safer alternative. EU-MDR Cla ss IIa Made in Germany Our commitment to excellence ensures that each device meets the highest standards of quality and performance, embodying the renowned precision of German engineering and manufacturing. With tVNS®, you’re choosing a device built on a foundation of durability and innovative design, trusted by healthcare professionals and researchers worldwide. EU-MDR Cla ss IIa Innovative App Integration Tracking and understanding your treatment progression is crucial. Our dedicated tVNS® Patient App not only provides real-time monitoring but also facilitates seamless sharing of data with healthcare professionals. EU-MDR Cla ss IIa Remote Flexibility In our modern age, the convenience of remote access is invaluable. tVNS® extends this by offering device delivery directly to your patient's doorstep and remote training. Your patient can initiate their treatment journey without the hassles or constraints of travel. Easy to Use Functionality should not compromise simplicity. The tVNS® device, while technologically advanced, is as intuitive as a smartphone, making integration into daily routines effortless. Clinical Evidence: The Science behind tVNS® Discover the proven effectiveness and safety of tVNS®, highlighted by pivotal clinical trials and studies. Our unique focus on cymba concha stimulation, quality control and clinical evidence, positions tVNS® as the preferred choice among researchers, ensuring we lead in neurotherapeutic innovation and patient care. Epilepsy After a 20 week treatment period, active tVNS® patients recorded an average 34.2% reduction of seizure frequency. Prader-Willi-Syndrome After a treatment period of 12 months, 80% of tVNS® patients recorded a reduction of mean number of outbursts per day of 50%, compared to mean number of outburst per day before treatment. Migraines Treatment with tVNS® led to a reduction of 50% of the frequency of days with migraines after a treatment period of 12 weeks. Depression tVNS® led to a reduction of depression-specific HAMD score of minimum 2-3 points in adult patients when used in parallel with psychopharmacological and psychotherapy treatments after a period of 9 weeks. tVNS Healing Stories Take the Next Step in Patient Care with tVNS® Discover the potential of tVNS® to transform the treatment landscape for your patients. Embrace a solution that offers a safe, non-invasive pathway to relief, especially for those who have explored conventional treatments without success. Join us in leading the way towards innovative, compassionate care. Connect with our qualified experts today to learn more about integrating tVNS® into your practice and how it can benefit your patients. Together, let’s pave the path to better health and improved quality of life. Name : Select inquiry: Choose an option Email : Country Please enter you message here Code Phone (optional) I have read and agree to the Privacy Policy Send Thanks for submitting!

tVNS® vagus therapy devices offer a non-surgical neuromodulation treatment option by providing auricular vagus nerve stimulation in difficult-to-treat brain diseases with the help of a smartphone-sized device and a special electrode. tVNS® Devices for Patients Be a part of your success story Buy tVNS Better days are ahead EU-MDR Cla ss IIa Certified Medical Device tVNS® is the world's only non-invasive vagus nerve stimulation approved as a Class IIa medical device under the EU-MDR, offering a scientifically validated treatment for conditions related to sympathovagal imbalance. Non-Invasive Approach A safe and gentle alternative to surgery and medication, tVNS® stimulates the vagus nerve through the skin, offering a harmonious path to wellbeing with very low side-effects. Most Effective Stimulation Site Minimal Side Effects tVNS® is the only non-invasive stimulation device that stimulates the cymba concha, resulting in 100% vagus nerve innervation (as opposed to e.g. the tragus, which only results in 45% innervation). Transitioning away from traditional medications often aims to reduce side effects. tVNS®, as a drug-free therapy, offers a safer alternative with lower risk of long-term adverse effects. tVNS® In the Media To play, press and hold the enter key. To stop, release the enter key. What is tVNS®? Navigating the world of medical treatments can be overwhelming, especially when faced with persistent and challenging health issues. Whether you’ve been tirelessly seeking effective solutions, or if traditional drug therapies have been unsuccessful, there is another option: tVNS® . The vagus nerve, central to our body’s nervous system, plays a critical role in maintaining homeostasis. tVNS®, or Transcutaneous Vagus Nerve Stimulation , harnesses the therapeutic potential of this nerve through targeted stimulation of its auricular branch, accessible within the ear. This innovative approach utilizes gentle electrical impulses to modulate the vagus nerve’s activity, encouraging a state of balance across the body’s systems. The result? A reduction in the symptoms of neurological diseases associated with sympathovagal imbalance, achieved through a method that avoids the invasiveness of surgery and the side effects associated with medication. Approved as a Class IIa medical device under the European Medical Device Regulation (MDR), tVNS® sets a new standard in the treatment of neurological conditions, offering a blend of efficacy, safety, and simplicity. Non-invasive vagus nerve stimulation for the treatment of neurological diseases tVNS® is indicated to treat the following conditions: ✓Depression ✓Epilepsy ✓Chronic Migraines ✓Prader-Willi Syndrome tVNS® Devices are Trusted by Leading Institutions Worldwide To play, press and hold the enter key. To stop, release the enter key. Why choose our tVNS® devices? Our tVNS® device is the only non-invasive vagus nerve stimulator that is approved as a Class IIa medical device under the European Medical Device Regulation (EU-MDR). tVNS® sets itself apart with its non-invasive, clinically validated approach, offering a safer and more comfortable alternative to invasive methods. Uniquely targeting the cymba concha for 100% innervation of the auricular branch of the vagus nerve (ABVN) with our patented electrode, tVNS® ensures maximum efficacy compared to other devices that only achieve partial innervation. EU-MDR Cla ss IIa Approved Medical Device Our tVNS® device is the only non-invasive vagus nerve stimulation (VNS) device that is approved as a medical device under the EU-MDR. It uniquely targets the Cymba Concha for 100% innervation of the auricular branch of the vagus nerve, unlike other devices that stimulate other areas and are not manufactured under the same quality and safety standards. EU-MDR Cla ss IIa Non-Surgical Approach tVNS® offers the efficacy of vagus nerve stimulation without the complexities or risks of surgical interventions. This means meaningful therapeutic benefits, all under your control, without invasive procedures. EU-MDR Cla ss IIa Minimal Side Effects Transitioning away from traditional medications often comes with the pursuit of fewer side effects. tVNS®, being drug-free, ensures a therapeutic experience with reduced potential for long-term adverse outcomes, positioning itself as a safer alternative. EU-MDR Cla ss IIa Made in Germany Our commitment to excellence ensures that each device meets the highest standards of quality and performance, embodying the renowned precision of German engineering and manufacturing. With tVNS®, you’re choosing a device built on a foundation of durability and innovative design, trusted by healthcare professionals and researchers worldwide. EU-MDR Cla ss IIa Innovative App Integration Tracking and understanding your treatment progression is crucial. Our dedicated tVNS® Patient App not only provides real-time monitoring but also facilitates seamless sharing of data with your healthcare professionals. EU-MDR Cla ss IIa Remote Flexibility In our modern age, the convenience of remote access is invaluable. tVNS® extends this by offering device delivery directly to your doorstep and remote training. Initiate your treatment journey without the hassles or constraints of travel. Easy to Use Functionality should not compromise simplicity. The tVNS® device, while technologically advanced, is as intuitive as a smartphone, making integration into daily routines effortless. How does tVNS® work? tVNS ® Patient Devices - tVNS ® E tVNS® vagus therapy devices offer a non-surgical neuromodulation treatment option by providing auricular vagus nerve stimulation in difficult-to-treat brain diseases with the help of a smartphone-sized device and a special electrode. With its innovative mobile application, the patient can share all the treatment information with a single click without leaving his home, and reach the necessary follow-up and support. tVNS® stimulates the branch of the vagus nerve in the auricle through the skin with gentle electrical impulses. Signals are passed on to the brain via special nerve fibers: first in the brain stem and then in higher centers. The treatment with tVNS® is applied by patients independently. It has been used by thousands of patients and is a treatment with very few side effects. Developed and manufactured in Germany, our devices meet the highest quality standards, reflecting our dedication to excellence and the well-being of our patients Download the tVNS® Patient App The innovative tVNS® Patient App is a wellness and session-diary application designed to help users keep a record of their well-being and the duration of their stimulation sessions. The tVNS® Patient App is available now in the Google Play Store and in the Apple App Store (EU-only). tVNS® Patient is fully compliant with the General Data Protection Regulation (GDPR), ensuring that patient data is handled with the utmost care and confidentiality. Clinical Evidence: The Science behind tVNS® Discover the proven effectiveness and safety of tVNS®, highlighted by pivotal clinical trials and studies. Our unique focus on cymba concha stimulation, quality control and clinical evidence, positions tVNS® as the preferred choice among researchers, ensuring we lead in neurotherapeutic innovation and patient care. Epilepsy After a 20 week treatment period, active tVNS® patients recorded an average 34.2% reduction of seizure frequency. Prader-Willi-Syndrome After a treatment period of 12 months, 80% of tVNS® patients recorded a reduction of mean number of outbursts per day of 50%, compared to mean number of outburst per day before treatment. Migraines Treatment with tVNS® led to a reduction of 50% of the frequency of days with migraines after a treatment period of 12 weeks. Depression tVNS® led to a reduction of depression-specific HAMD score of minimum 2-3 points in adult patients when used in parallel with psychopharmacological and psychotherapy treatments after a period of 9 weeks. tVNS Healing Stories Take the next step with tVNS® - for a life without limitations. Every day presents an opportunity. Yet, for those navigating the challenges of medical conditions, some days can feel overshadowed by discomfort or uncertainty. With tVNS® , we aim to bring a brighter shade to every day. By harnessing the power of neurostimulation, our tVNS® device aims to pave the way for more pain-free days, empowering patients to lead self-determined lives. It’s not merely about symptom relief, it’s about reclaiming the essence of each day, savoring moments with loved ones, and pursuing passions without being held back by your condition. tVNS® is approved for the treatment of the following indications. Anxiety Atrial Fibrillation Autism Cognitive Impairment Crohn's disease (IBD) Depression Epilepsy Migraine Parkinson's Prader-Willi Syndrome Sleeping disorders Systematic Sclerosis Tinnitus Contact Our Global tVNS Experts Worldwide Name : Select inquiry: Choose an option Email : Country Please enter you message here Code Phone (optional) I have read and agree to the Privacy Policy Send Thanks for submitting! Contact Our Global tVNS Experts Worldwide Name : Select inquiry Choose an option Email : Country Please enter you message here Code Phone (optional) I have read and agree to the Privacy Policy Send Thanks for submitting!

tVNS non-surgical tvns treatment for cognitive impairment, dementia and alzheimer's. The most up-to-date health information on cognitive impairment causes, symptoms, and treatment options Cognitive Impairment Groundbreaking Technologies for Life What is Cognitive Impairment? The shrinkage caused by the loss of cells in the brain causes various functional disorders. These dysfunctions may manifest as dementia, Alzheimer, and mild cognitive impairment, which are comm on in people ives. People with cognitive impairment are at high risk for Alzheimer and dementia. When adequate precautions are taken, cognitive impairment may regress, and it is possible for these people to lead a normal life. Types of Cognitive Disorder Demantia It is the inadequacies experienced in language, skills and orientation, especially forgetfulness. Dementia is a family that includes many different types. There are Alzheimer's, dementia due to c hronic cerebrovascular disease, alcoholic dementia, depr essive dementia, dementia due to infections, etc. Dementia occurs as a result of general deterioration of the upper level functions of the cerebral cortex, especially over 75 years of age, with advancing age. There are dementias that start with memory impairment such as Alzheimer's disease, as well as behavioral disorders, skill disorders, depression, There are also dementias that start with the symptoms of parkinson's disease and language disorders. It is a progressive disease. Alzhemeir It is the most common type of dementia is a neurological disease that causes the destruction of brain cells. The disease, which causes a decrease in thought, memory and behavioral functions, occurs after a long time with advancing age. It may take years for the disease to reach advanced stages. Because it is a progressive disease, Alzheimer's patients experience problems such as inability to perform their daily tasks, forgetfulness and serious confusion. People with memory loss or other possible Alzheimer's symptoms may have trouble recognizing that they have a problem. Treatment Options for Cognitive Disorder There is no drug therapy approved to treat cognitive impairment. Medicines used to treat symptoms of Alzheimer's disease have been tried. Some studies have found that using these drugs for cognitive impairment is helpful, while others have concluded that there is no benefit. It has been noted that the use of other drugs, including NSAIDs, Ginkgo, Biloba and vitamin E, does not provide a great benefit. tVNS Effect Mechanism There are many clinical studies in recent years that cognitive disorders are caused by inflammation in the brain. Although the basic efficacy mechanism of tVNS has not been fully resolved, our new generation devices in 2021 became the first neuromodulation therapy approved for cognitive impairment in the world, due to both its benefits in the treatment of inflammation and the increase in neuroplasticity. Contact us

Non-surgical, drug-free, low side-effect treatment for tVNS migraine. The most up-to-date health information about migraine causes, symptoms, treatment options Migraines Migraines manifest as a neurological disorder characterized by an intense, pulsating headache, frequently concentrated on one side of the head. Unique features setting migraines apart from other headaches include nausea, vomiting, and heightened sensitivity to sound and light. The intensity of the pain often hinders the performance of daily tasks, resulting in limitations. Notably, migraine attacks stand as a primary contributor to disability and work-related absence in developed nations Less migraines - more from life. Treatment Options for Migraines Acupuncture Treatment One of the most commonly used treatment methods for migraine treatment in western countries is acupuncture. Acupuncture has the ability to increase the release of endorphins in the body which act as powerful pain relievers. At the same time, acupuncture also activates calming chemicals in the body. Botulinum Toxin Treatment Another treatment method in chronic migraine patients is botulinum toxin treatment, which has been applied since 2010. The frequency and severity of pain can be reduced by applying it to patients who use too many painkillers and are unresponsive to other treatments. This treatment is generally well tolerated and there are no serious side effects. Dry Needle Therapy Dry needle therapy is a drug-free, scientific treatment method based on the stimulation of the trigger points in the muscles in different parts of the body using special needles of different sizes. Migraine Surgery Migraine surgery is the intervention of the nerve branches located in the forehead, temples, neck and nape root of the migraine-related regions of the brain, and to the vessels and muscles around these nerve branches. With surgery, these anatomical structures may be permanently damaged, nerve endings may be damaged and ‘neuropathic pains’ may occur. Anti-CGRP Injection CGRP plays a key role in dilating or widening blood vessels. The injection works to block the sites in and around the brain in place of CRGP or binds directly to CGRP and prevents it from being effective. The effects are not yet known. Medications that lower CRGP may cause side effects that affect your blood pressure and heart. Transcutaneous Vagus Nerve Stimulation The tVNS® auricular vagus stimulation device is a treatment option that provides vagus nerve stimulation through the ear with a smartphone-sized device and a special headset without any surgical intervention. How does tVNS® treat migraines? The focus of migraine therapy with tVNS® is the activation of the parasympathetic part of the autonomic nervous system. This part of the nervous system is always active when we are relaxing or resting and is responsible for cell regeneration and metabolic processes. The stimulation of the parasympathetic nervous system triggers the necessary regeneration processes of inflammatory areas and acts as a recovery accelerator. Neurostimulation with tVNS® is used both as a migraine prophylaxis and during an acute attack. While drugs are taken orally and thus develop their effect systematically, they are often accompanied by numerous undesirable side effects. Therapy with tVNS® , on the other hand, has the advantage that it activates the parasympathetic system directly by stimulating the vagus nerve on the ear and has very few side effects. tVNS® has helped hundreds of patients suffering from migraines to reduce or completely eliminate migraines and lead a more self-determined life. “The idea of treating migraine without medication appealed to me immediately. And now, a year and a half after the first application, I have a completely new quality of life.” M. Dohring from Berlin Contact Us

Excessive drug use in children can cause developmental delay. tVNS provides long-term positive results by reducing the need for drug use. tVNS is safe for children and approved for pediatric use. tVNS provides benefits in mental development and motor development. Use of tVNS® in Children tVNS is safe for children and MDR CE approved for pediatric use Epilepsy, Autism, Prader Willy Syndrom are the approved indications Young children should use the device under parental supervision. Excessive drug use in children can cause developmental delay. tVNS provides long-term positive results by reducing the need for drug use. Reducing drug use helps prevent the side effects of anti-epileptic drugs Improves energy, concentration, and mood Children who are using the therapy in the long term can experience cognitive and motor improvement

tVNS Health Services and Solutions: At tVNS Health GmbH, we offer distinctive solutions and services tailored for the tVNS device ecosystem. Our expertise includes training healthcare professionals and organizations in the essentials of the therapy and device operation. Additionally, we extend online training and personalized therapy tracking services to patients and their families. This ensures the proper utilization of the devices, maximizing the benefits derived from this innovative technology. With a passion for solving unmet needs, we bring together technology, neuromodulation expertise and leading opinion leaders to create never-before-seen solutions. tVNS® Academy Training Our tVNS Training Services are designed to support patients as they begin their journey with transcutaneous vagus nerve stimulation (tVNS). We offer personalized, 1-on-1 training sessions tailored to individual needs, providing patients with expert guidance every step of the way. Access a range of online training materials and connect with a dedicated therapy consultant fluent in multiple languages for continuous support and assistance, ensuring a smooth and effective therapy experience. Contact our team tVNS® Care Services Our online tracking services aim patients achieve optimal results by accurately monitoring therapy, verifying the device utilization and compliance to the therapy plan. In addition, we offer access to a network of physicians experienced in transcutaneous vagus nerve neuromodulation therapy, providing professional consultation and guidance tailored to each patient's needs. Contact our team tVNS® Rental Services For doctors and patients interested in experiencing the benefits of our device before making a purchase, we offer customized rental service for different requirements and indications. Check the availability of this service in your country to start your trial today. Contact our team Request for Information

tVNS treatment in sleep disorders. The most up-to-date health information on sleep disorders causes, symptoms, treatment options INSOMNIA (SLEEP DISORDER) What is Insomnia? Insomnia is a common sleep disorder that makes it difficult to fall asleep and stay asleep, or to wake up too early and not be able to go back to sleep. People with insomnia feel tired when they wake up. Insomnia can reduce not only energy level and mood, but also health, work performance and quality of life. It is the disease of not being able to sleep in sufficient time and restful sleep. During the existence of the disease, symptoms such as irregularity in sleeping hours, sudden night awakenings, difficulty falling asleep after waking up, and waking up very early in the morning are observed. The existence of a regular sleep time and long naps does not mean that we will wake up the next day rested and ready to work. In studies on sleep and sleeping problems, it is said that an adult individual should sleep 7-8 hours every night. However, the resting process, which differs from person to person, can change the person's sleep duration. Types of Insomnia Acute insomnia: It refers to the short-term appearance of insomnia. Acute insomnia usually occurs after a stressful day or on days when mental tension is high. Our body clock has a hard time showing when it's time to rest on such difficult days. This irregularity, which usually lasts for 1 to 2 days, continues unti l we feel better. There are signs of acute insomnia that can last up to 4 weeks. Chronic Insomnia: A sleep disorder that lasts for 1 month or more is called chronic insomnia. A large proportion of 10-15% of adults suffer from chronic insomnia. Compared to acute insomnia, chronic insomnia requires medical attention. The main cause of this type of disorder is usually the presence of major depression. Hypersomnia: characterized by excessive sleepiness and excessive daytime sleep requirements. It is less common than insomnia. Narcolepsy : Includes excessive daytime sleepiness and abnormal findings in daily REM sleep for at least 3 months. Narcolepsy is an abnormality in the sleep mechanism, especially in the REM mechanism. Treatment Options for Insomnia Sleep Techniques Airflow in and out of the lungs during breathing Blood oxygen levels. Body position. Brain waves (EEG) More information CPAP Titration (Mask Therapy) Some cases of severe depression require a hospital stay. This may be necessary in situations where the individual is unable to take care of themselves properly and is in danger of harming themselves or someone else. More information Polysomnography Sleep test. It is a process that is done by recording with the help of devices all night long to determine the quality of sleep and to find the cause of the sleep disorder. More information Transcutaneous Vagus Nerve Stimulation (tVNS) Communication between the gut and the brain is provided by the vagus nerve. More information WE DESIGN THE MEDICAL TECHNOLOGIES OF THE FUTURE Contact us

During the last 20 years, basic and clinical research has unraveled many of these questions and augmented our understanding of tVNS pathways and physiologic effects. The number of publications increased exponentially within the last three years and continues to grow rapidly. Many questions have been addressed and therapeutic indications beyond the treatment of drug-resistant epilepsy and depression are steadily expanding and continue to be explored. Clinical Studies Vagus nerve stimulation (VNS) has become a therapeutic option for patients with resistant epilepsy and depression. The field of tVNS is quickly progressing due to its non-invasive nature, presenting a promising alternative to the side effects associated with invasive VNS. Notably, tVNS stands out for its accessibility, affordability, and easiness of application compared to traditional VNS methods. However, the non-invasive stimulation of the outer ear brings forth new queries regarding optimal stimulation sites, stimulus parameters, and the physiological pathways of transcutaneous auricular VNS. Over the past two decades, both basic and clinical research have made significant strides, unraveling these complexities, enhancing our comprehension of tVNS pathways and physiological effects. The exponential growth in publications over the last years underscores the expanding knowledge base. As we delve deeper, therapeutic applications and achievable objectives of tVNS beyond epilepsy and depression treatment are continually broadening, promising new horizons in the field. Redgrave 2018: Safety and Tolerability of tVNS Wrede Case Study 2019 : Sustained seizure freedom with transcutaneous vagal nerve stimulation in drug-resistant epilepsy caused by subcortical band heterotopias Yakunina 2016: Optimization of Transcutaneous Vagus Nerve Stimulation Using Functional MRI Ellrich 2019: Transcutaneous Auricular Vagus Nerve Stimulation Study Bauer 2015: Transcutaneous Vagus Nerve Stimulation (tVNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial Straube 2015: Treatment of chronic migraine with Transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial tVNS JOURNAL The "tVNS Special Issue", which includes 17 studies on our tVNS devices, has been published in the "Journal Autonomic Neuroscience" by Elsevier, the official journal of the International Society for Autonomic Neuroscience. Journal For more please contact us info@tvns.health

Explore our current partnerships and discover opportunities to join us in distributing our tVNS® devices. Shaping the Future of Non-Invasive Healing. Together. Explore our current partnerships and discover opportunities to join us in distributing our tVNS® devices. Distributor Services tVNS Health GmbH offers: Access to tVNS ® Neuromodulation Academy: for training of the new distributors on tVNS devices and transcutaneous vagal neuromodulation Support on local marketing, sales training and go-to-market strategy Support on onboarding activities Become a tVNS Distributor tVNS Health Gmbh is the distribution and service gateway to a game-changer neuromodulation product - tVNS® auricular vagus nerve stimulation device - from tVNS Technologies GmbH in selected countries in Europe, and all regions in Asia, Africa, Oceania, and South America.

tVNS Health Gmbh is a medical technology sales company based in Grünwald, Germany, that has been responsible for the global distribution, services, and operations management of tVNS devices. About Us tVNS Health Gmbh is a medical technology sales company based in Germany, responsible for the global distribution, services, and sales of tVNS® non-invasive auricular vagus nerve stimulation devices in Eastern Europe, Scandinavia, Asia, Africa, South America and Italy. The developer and manufacturer of tVNS® devices is tVNS Technologies GmbH based in Erlangen, Germany. Since the medical approval of the Cerbomed Nemos® device as a first non-invasive auricular vagus nerve stimulation medical device in 2010, Cerbomed Nemos® and the new tVNS® have been used in thousands of treatments globally and significantly improved patients' quality of life. Meet the Founders Berkay Gezen is an enthusiastic professional with 28+ global business development and medical brand management. He has served as the global commercial director of CardiAid, brand for 11 years, from the design of the brand to its expansion in over 65 countries of the world. Following his creative vision of AED and his experience in global development, he became the founder of tVNS Health to focus on neuromodulation and vagus nerve stimulation technologies, sales, services and distribution for tVNS. With his expertise in market building, he become the implementer of projects that make a difference in more than 80 countries of the world. He has dedicated his professional life to increasing the awareness of public access defibrillators and neuromodulation. With his motivation, he inspires the medical community and continues to manage medical channel in more than 50 countries worldwide. Selin Erdogan Gezen Selin Erdogan Gezen She is a visionary leader in the field of neuromodulation technologies and global business development. After pivotal roles in renowned companies like Vodafone, Garanti BBVA Bank, and Hewlett Packard, as program management in innovative technology projects, Selin embarked on a new chapter as a founding partner of Nervovita Medical Technologies and tVNS Health, focusing on neuromodulation therapies. Her dedication led to the accessibility of transcutaneous vagal nerve stimulation, revolutionizing treatment options around the globe. She collaborates with leading universities and institutes in over 40 countries, driving clinical studies across various diseases. She is designing the human-machine interaction for better usability of wearable medical devices. "Our mission is to empower individuals worldwide with innovative neuromodulation and bio-electronic solutions that enhance well-being and improve lives. Committed to advancing healthcare through cutting-edge technology, we strive to be the global leader in distributing the transcutaneous vagus nerve stimulation devices. Guided by a dedication to excellence, integrity, and social responsibility, our company aims to establish a pervasive presence in the global market, ensuring accessibility to the transformative benefits of the tVNS devices. We are driven by a passion for improving mental and physical health, fostering a world where individuals can achieve their full potential and lead fulfilling lives. Our commitment extends beyond the distribution; we aim to build enduring partnerships with healthcare professionals, research institutions, and distributors to foster a collaborative ecosystem. By prioritizing customer satisfaction, continuous innovation, and ethical business practices, we aim to create a positive impact on the well-being of communities around the globe." Our Mission Our Vision "We envision a future where transformative neuromodulation technology becomes an integral part of global healthcare, revolutionizing the way individuals manage and enhance their well-being. Guided by innovation, compassion, and a commitment to excellence, we aspire to establish ourselves as the foremost global influence, ensuring universal access, recognition, and trust in the widespread expansion of transcutaneous vagus nerve stimulation technologies (taVNS). We aspire to lead the charge in advancing the field of neuromodulation, continuously pushing the boundaries of what is possible to unlock the full potential of the human body's innate healing mechanisms. By fostering a culture of curiosity, collaboration, and inclusivity, we aim to inspire a global movement toward proactive and personalized healthcare solutions. Through strategic partnerships, ongoing research, and a commitment to ethical business practices, we seek to shape a healthcare landscape where preventative and holistic approaches are celebrated. As we strive for excellence, our vision extends beyond business success to contributing significantly to the betterment of society. We see a world where the neuromodulation becomes a beacon of hope, fostering resilience, and promoting a culture of well-being that transcends borders. We are dedicated to pioneering a future where the power of neuromodulation transforms lives, creating a healthier, happier, and more connected global community." tVNS Health GmbH Headquarter Südliche Münchner Str. 62, 82031 Grünwald, Germany info@tvns.health www.tvns.health Contact tVNS Health info@tvns.health Contact Form

Time Out This page isn’t available right now. But we’re working on a fix, ASAP. Try again soon. Go Back